Complement 3 deficiency: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
[[File:Protein_C3_PDB_1c3d.png|Protein C3 PDB 1c3d|thumb]] '''Complement 3 deficiency''' is a rare [[immunodeficiency]] disorder characterized by the body's inability to produce a sufficient amount of Complement component 3 (C3), a crucial protein in the [[immune system]]. C3 plays a vital role in the activation of the [[complement system]], a part of the immune system that enhances the ability of [[antibodies]] and phagocytic cells to clear pathogens from an organism. This deficiency can lead to an increased susceptibility to bacterial infections, particularly infections caused by encapsulated bacteria, and can also contribute to the development of autoimmune conditions. | {{SI}} | ||
{{Infobox medical condition | |||
| name = Complement 3 deficiency | |||
| image = [[File:Protein_C3_PDB_1c3d.png|250px]] | |||
| caption = Structure of Complement C3 | |||
| field = [[Immunology]] | |||
| symptoms = [[Recurrent infections]], [[autoimmune diseases]] | |||
| complications = [[Sepsis]], [[glomerulonephritis]] | |||
| onset = Congenital or acquired | |||
| duration = Chronic | |||
| causes = Genetic mutations, acquired factors | |||
| risks = Increased susceptibility to infections | |||
| diagnosis = [[Complement system]] assays, genetic testing | |||
| differential = Other complement deficiencies, [[immunodeficiency]] disorders | |||
| treatment = [[Antibiotics]], [[immunoglobulin therapy]] | |||
| prognosis = Variable, depends on severity and management | |||
| frequency = Rare | |||
}} | |||
[[File:Protein_C3_PDB_1c3d.png|Protein C3 PDB 1c3d|left|thumb]] '''Complement 3 deficiency''' is a rare [[immunodeficiency]] disorder characterized by the body's inability to produce a sufficient amount of Complement component 3 (C3), a crucial protein in the [[immune system]]. C3 plays a vital role in the activation of the [[complement system]], a part of the immune system that enhances the ability of [[antibodies]] and phagocytic cells to clear pathogens from an organism. This deficiency can lead to an increased susceptibility to bacterial infections, particularly infections caused by encapsulated bacteria, and can also contribute to the development of autoimmune conditions. | |||
==Causes== | ==Causes== | ||
Complement 3 deficiency is most often caused by a genetic mutation that affects the production or function of the C3 protein. These mutations are typically inherited in an [[autosomal recessive]] manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition. | Complement 3 deficiency is most often caused by a genetic mutation that affects the production or function of the C3 protein. These mutations are typically inherited in an [[autosomal recessive]] manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition. | ||
==Symptoms== | ==Symptoms== | ||
The symptoms of Complement 3 deficiency can vary widely among individuals but commonly include an increased susceptibility to infections, particularly those caused by encapsulated bacteria such as [[Streptococcus pneumoniae]], [[Haemophilus influenzae]], and [[Neisseria meningitidis]]. These infections can be recurrent and severe. Additionally, individuals with Complement 3 deficiency may experience autoimmune problems, such as [[systemic lupus erythematosus]] (SLE) or [[glomerulonephritis]], due to the immune system attacking the body's own tissues. | The symptoms of Complement 3 deficiency can vary widely among individuals but commonly include an increased susceptibility to infections, particularly those caused by encapsulated bacteria such as [[Streptococcus pneumoniae]], [[Haemophilus influenzae]], and [[Neisseria meningitidis]]. These infections can be recurrent and severe. Additionally, individuals with Complement 3 deficiency may experience autoimmune problems, such as [[systemic lupus erythematosus]] (SLE) or [[glomerulonephritis]], due to the immune system attacking the body's own tissues. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Complement 3 deficiency typically involves blood tests to measure the levels of complement proteins in the blood. Low levels of C3, in the presence of normal levels of other complement components, may suggest a diagnosis of Complement 3 deficiency. Further genetic testing may be conducted to identify specific mutations in the genes responsible for C3 production. | Diagnosis of Complement 3 deficiency typically involves blood tests to measure the levels of complement proteins in the blood. Low levels of C3, in the presence of normal levels of other complement components, may suggest a diagnosis of Complement 3 deficiency. Further genetic testing may be conducted to identify specific mutations in the genes responsible for C3 production. | ||
==Treatment== | ==Treatment== | ||
There is no cure for Complement 3 deficiency, and treatment focuses on managing symptoms and preventing infections. This may include the use of [[antibiotics]] to treat and prevent bacterial infections and immunosuppressive drugs to manage autoimmune symptoms. In some cases, [[vaccination]] against encapsulated bacteria may be recommended to reduce the risk of infection. | There is no cure for Complement 3 deficiency, and treatment focuses on managing symptoms and preventing infections. This may include the use of [[antibiotics]] to treat and prevent bacterial infections and immunosuppressive drugs to manage autoimmune symptoms. In some cases, [[vaccination]] against encapsulated bacteria may be recommended to reduce the risk of infection. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with Complement 3 deficiency varies depending on the severity of the condition and the presence of associated autoimmune disorders. With appropriate treatment and management of infections, individuals can lead relatively normal lives. However, they may require ongoing medical care to manage the increased risk of infections and autoimmune complications. | The prognosis for individuals with Complement 3 deficiency varies depending on the severity of the condition and the presence of associated autoimmune disorders. With appropriate treatment and management of infections, individuals can lead relatively normal lives. However, they may require ongoing medical care to manage the increased risk of infections and autoimmune complications. | ||
[[Category:Immunodeficiency]] | [[Category:Immunodeficiency]] | ||
[[Category:Genetic diseases and disorders]] | [[Category:Genetic diseases and disorders]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 02:13, 5 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Complement 3 deficiency | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Recurrent infections, autoimmune diseases |
| Complications | Sepsis, glomerulonephritis |
| Onset | Congenital or acquired |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutations, acquired factors |
| Risks | Increased susceptibility to infections |
| Diagnosis | Complement system assays, genetic testing |
| Differential diagnosis | Other complement deficiencies, immunodeficiency disorders |
| Prevention | N/A |
| Treatment | Antibiotics, immunoglobulin therapy |
| Medication | N/A |
| Prognosis | Variable, depends on severity and management |
| Frequency | Rare |
| Deaths | N/A |

Complement 3 deficiency is a rare immunodeficiency disorder characterized by the body's inability to produce a sufficient amount of Complement component 3 (C3), a crucial protein in the immune system. C3 plays a vital role in the activation of the complement system, a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear pathogens from an organism. This deficiency can lead to an increased susceptibility to bacterial infections, particularly infections caused by encapsulated bacteria, and can also contribute to the development of autoimmune conditions.
Causes[edit]
Complement 3 deficiency is most often caused by a genetic mutation that affects the production or function of the C3 protein. These mutations are typically inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition.
Symptoms[edit]
The symptoms of Complement 3 deficiency can vary widely among individuals but commonly include an increased susceptibility to infections, particularly those caused by encapsulated bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. These infections can be recurrent and severe. Additionally, individuals with Complement 3 deficiency may experience autoimmune problems, such as systemic lupus erythematosus (SLE) or glomerulonephritis, due to the immune system attacking the body's own tissues.
Diagnosis[edit]
Diagnosis of Complement 3 deficiency typically involves blood tests to measure the levels of complement proteins in the blood. Low levels of C3, in the presence of normal levels of other complement components, may suggest a diagnosis of Complement 3 deficiency. Further genetic testing may be conducted to identify specific mutations in the genes responsible for C3 production.
Treatment[edit]
There is no cure for Complement 3 deficiency, and treatment focuses on managing symptoms and preventing infections. This may include the use of antibiotics to treat and prevent bacterial infections and immunosuppressive drugs to manage autoimmune symptoms. In some cases, vaccination against encapsulated bacteria may be recommended to reduce the risk of infection.
Prognosis[edit]
The prognosis for individuals with Complement 3 deficiency varies depending on the severity of the condition and the presence of associated autoimmune disorders. With appropriate treatment and management of infections, individuals can lead relatively normal lives. However, they may require ongoing medical care to manage the increased risk of infections and autoimmune complications.
